Search This Blog

Thursday, December 14, 2023

Ambrx to be Added to the NASDAQ Biotechnology Index

 Ambrx Biopharma, Inc., or Ambrx, (NASDAQ: AMAM), today announced that the Company will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective prior to the market open on Monday, December 18, 2023.

https://www.globenewswire.com/news-release/2023/12/14/2796288/0/en/Ambrx-to-be-Added-to-the-NASDAQ-Biotechnology-Index-NBI.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.